Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.
about
Psychedelics and the human receptoromeThe entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugsDARPP-32 mediates the actions of multiple drugs of abuseAdverse consequences of lysergic acid diethylamideSalvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonistHead-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.Human hallucinogen research: guidelines for safetyThe HIV antiretroviral drug efavirenz has LSD-like propertiesPsilocybin occasioned mystical-type experiences: immediate and persisting dose-related effectsMultiple receptors contribute to the behavioral effects of indoleamine hallucinogens.Neural correlates of the psychedelic state as determined by fMRI studies with psilocybinPsychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actionsMystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of opennessGuinea pig hippocampal 5-HT(1E) receptors: a tool for selective drug developmentThe behavioral pharmacology of hallucinogensArresting serotoninEpigenetic mechanisms in schizophreniaMechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortexLysergic acid diethylamide: a drug of 'use'?Preclinical models of antipsychotic drug action.Recent advances in the neuropsychopharmacology of serotonergic hallucinogensd-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.Caveolin-1 interacts with 5-HT2A serotonin receptors and profoundly modulates the signaling of selected Galphaq-coupled protein receptorsCellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult ratPsychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.PsychedelicsLooking for the Self: Phenomenology, Neurophysiology and Philosophical Significance of Drug-induced Ego Dissolution.PSD-95 is essential for hallucinogen and atypical antipsychotic drug actions at serotonin receptorsLSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor.Genetic variation in the serotonin 2A receptor and suicidal ideation in a sample of 270 Irish high-density schizophrenia families.Serotonergic/glutamatergic interactions: potentiation of phencyclidine-induced stimulus control by citalopram.Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors.The 5-HT1A receptor and the stimulus effects of LSD in the rat.Psychedelic drug use in healthy individuals: A review of benefits, costs, and implications for drug policyHallucinogen actions on human brain revealed.Effects of clozapine and 2,5-dimethoxy-4-methylamphetamine [DOM] on 5-HT2A receptor expression in discrete brain areas.The hallucinogenic world of tryptamines: an updated review.The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A inhibit enteric cholinergic transmission in the guinea-pig ileum.Hallucinogens, serotonin and obsessive-compulsive disorder.LSD and DOB: interaction with 5-HT2A receptors to inhibit NMDA receptor-mediated transmission in the rat prefrontal cortex.
P2860
Q21090031-620A5660-9C47-4B42-BE9B-1785ABFA774DQ21129387-B14152BF-8E0F-4791-BAE3-6318D1BF8E6EQ22241668-0E3E4335-2E53-442E-A388-396961486743Q22242641-763B571D-C46E-41E3-AB56-CB9B3BBE3121Q24535736-4536483F-527B-42A4-8CCB-E9DA1257D7DAQ24595389-605BD36F-374D-49EE-ABA5-877408F83B9EQ24600704-D375FF13-A526-41B5-8BF7-48CF7189E7C6Q24608183-6E4A4C1B-CFE8-4A6B-AEB2-D0199382A4D9Q24613764-B9C1A0AB-BF16-4B36-BDD2-28AEF4EE06B0Q24620764-B6AD8D78-7FC2-4877-B38E-BC8F71190008Q24633222-4E8FB1CB-709C-480C-9E1D-E340BDF6E8DDQ24633393-41DE74CD-458B-4405-AD89-40D985A1585DQ24634013-0E060F9E-0B0A-41C7-8358-4072B31365A7Q24643885-0AB2FF1C-9460-485A-9BDE-F23F5E5ED54BQ24645656-DA1DC88A-B8F1-40F7-AE79-5862612D5736Q24647492-0465FE4C-2B16-4973-B049-11F0DBF43BFDQ24654169-C8D40118-966A-470F-B84B-A2AFD2F37EB4Q24676304-2144223B-3AAB-4C9E-8D9D-206C07D6CC4BQ26746133-26415D3A-37CE-4143-BDCA-999FDC8F5921Q26827502-E50112EA-053B-4DB3-9CB3-4B9E26BCD9BEQ27027381-F7BCA995-DB01-4F93-8E30-1FF354CB5B1FQ28067851-96936AF3-27C5-461A-8EEA-FA303F03B2BFQ28266342-8EA6BCCF-F5ED-4D14-87DA-405CF32D2932Q28565096-BC06A64E-8CA0-4988-BC0E-B241FCAB166AQ30249553-CBDCCF49-E88F-4FE5-8052-739FCB292F54Q30359998-DEBA5A63-6CBF-436F-B21D-B7F4F08FEAC6Q30402789-6DFA0373-2EF3-486F-B185-50ED0FBF96D9Q30482703-BFB6206E-87CC-4085-A9EB-E61EC008FFC9Q30484494-E2B6D194-668D-47E4-867B-30B0F80CAC28Q33750910-5BBB0F09-5239-4ADA-A5FE-27A2FAB4516FQ34016393-6357A2BF-D9FB-4A5E-80F9-AFDB6658265FQ34087847-F8391A30-A6BC-43C2-83E1-68F22F85FB59Q34099158-CD099FD4-1AE1-4166-9375-79344AB306F2Q34178760-3B456F56-5E4B-4BCE-879F-C1D5B56E722DQ34252419-E63E3387-74D8-4A89-BBC3-1F4731392141Q34313092-33BC0A05-7301-4837-B3B3-F65AF64616F2Q34471834-AAD7BF43-6E6F-47BC-A943-39382A983955Q34478698-6FFBA56A-0916-4111-BC86-90610FDA25E4Q34489965-5F2AE595-2FD4-460A-8307-E7D4AC6D95BBQ34505229-92A0FAB0-9F84-49CF-9AB2-0B548E15E55F
P2860
Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.
description
1984 nî lūn-bûn
@nan
1984 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.
@ast
Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.
@en
Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.
@nl
type
label
Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.
@ast
Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.
@en
Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.
@nl
prefLabel
Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.
@ast
Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.
@en
Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.
@nl
P2093
P1433
P1476
Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.
@en
P2093
Glennon RA
McKenney JD
P304
P356
10.1016/0024-3205(84)90436-3
P407
P577
1984-12-01T00:00:00Z